|
[1]
|
Siegel, R.L., Miller, K.D., Wagle, N.S., et al. (2023) Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians, 73, 17-48. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Miller, K.D., Fidler-Benaoudia, M., Keegan, T.H., et al. (2020) Cancer Statistics for Adolescents and Young Adults, 2020. CA: A Cancer Journal for Clinicians, 70, 443-459. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Deberardinis, R.J., Lum, J.J., Hatzivassiliou, G., et al. (2008) The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation. Cell Metabolism, 7, 11-20. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Dauer, P. and Lengyel, E. (2019) New Roles for Glycogen in Tu-mor Progression. Trends Cancer, 5, 396-399. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Domoto, T., Uehara, M., Bolidong, D., et al. (2020) Glycogen Synthase Kinase 3β in Cancer Biology and Treatment. Cells, 9, Article No. 1388. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Khan, T., Sullivan, M.A., Gunter, J.H., et al. (2020) Revisiting Glycogen in Cancer: A Conspicuous and Targetable Enabler of Malignant Transformation. Frontiers in Oncology, 10, Article ID: 592455. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Lin, J., Song, T., Li, C., et al. (2020) GSK-3β in DNA Repair, Apoptosis, and Resistance of Chemotherapy, Radiotherapy of Cancer. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1867, Article ID: 118659. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Zois, C.E. and Harris, A.L. (2016) Glycogen Metabolism Has a Key Role in the Cancer Microenvironment and Provides New Targets for Cancer Therapy. Journal of Molecular Medi-cine (Berl), 94, 137-154. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Di Mauro, S. (2007) Muscle Glycogenoses: An Overview. Acta Myologica, 26, 35-41.
|
|
[11]
|
Roach, P.J., Depaoli-Roach, A.A., Hurley, T.D., et al. (2012) Glycogen and Its Metabolism: Some New Developments and Old Themes. Biochemical Journal, 441, 763-787. [Google Scholar] [CrossRef]
|
|
[12]
|
Zhang, H., Ma, J., Tang, K., et al. (2021) Beyond Energy Storage: Roles of Glycogen Metabolism in Health and Disease. The FEBS Journal, 288, 3772-3783. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Marr, L., Biswas, D., Daly, L.A., et al. (2022) Mechanism of Glycogen Synthase Inactivation and Interaction with Glycogenin. Nature Communications, 13, Article No. 3372. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Uhlén, M., Fagerberg, L., Hallström, B.M., et al. (2015) Prote-omics. Tissue-Based Map of the Human Proteome. Science, 347, Article ID: 1260419. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
De Heer, E.C., Zois, C.E., Bridges, E., et al. (2023) Glycogen Syn-thase 1 Targeting Reveals a Metabolic Vulnerability in Triple-Negative Breast Cancer. Journal of Experimental & Clinical Cancer Research, 42, 143. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Chen, S.L., Huang, Q.S., Huang, Y.H., et al. (2020) GYS1 In-duces Glycogen Accumulation and Promotes Tumor Progression via the NF-κB Pathway in Clear Cell Renal Carcinoma. Theranostics, 10, 9186-9199. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Cameron, J.M., Levandovskiy, V., Mackay, N., et al. (2009) Identification of a Novel Mutation in GYS1 (Muscle-Specific Glycogen Synthase) Resulting in Sudden Cardiac Death, That Is Diag-nosable from Skin Fibroblasts. Molecular Genetics and Metabolism, 98, 378-382. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Conte, F., Sam, J.E., Lefeber, D.J., et al. (2023) Metabolic Car-diomyopathies and Cardiac Defects in Inherited Disorders of Carbohydrate Metabolism: A Systematic Review. Interna-tional Journal of Molecular Sciences, 24, Article No. 8632. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Embi, N., Rylatt, D.B. and Cohen, P. (1980) Glycogen Synthase Kinase-3 from Rabbit Skeletal Muscle. Separation from Cy-clic-AMP-Dependent Protein Kinase and Phosphorylase Kinase. European Journal of Biochemistry, 107, 519-527. [Google Scholar] [CrossRef]
|
|
[20]
|
Maurer, U., Preiss, F., Brauns-Schubert, P., et al. (2014) GSK-3—At the Crossroads of Cell Death and Survival. Journal of Cell Science, 127, 1369-1378. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Hoeflich, K.P., Luo, J., Rubie, E.A., et al. (2000) Requirement for Glyco-gen Synthase Kinase-3beta in Cell Survival and NF-kappaB Activation. Nature, 406, 86-90. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Medunjanin, S., Schleithoff, L., Fiegehenn, C., et al. (2016) GSK-3β Con-trols NF-kappaB Activity via IKKγ/NEMO. Scientific Reports, 6, Article No. 38553. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Zois, C.E., Favaro, E. and Harris, A.L. (2014) Glycogen Metabolism in Cancer. Biochemical Pharmacology, 92, 3-11. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Wadhwa, P., Jain, P. and Jadhav, H.R. (2020) Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors. Current Topics in Medicinal Chemistry, 20, 1522-1534. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Hardt, S.E. and Sadoshima, J. (2002) Glycogen Syn-thase Kinase-3beta: A Novel Regulator of Cardiac Hypertrophy and Development. Circulation Research, 90, 1055-1063. [Google Scholar] [CrossRef]
|
|
[26]
|
Shih, J.Y. and Yang, P.C. (2011) The EMT Regulator Slug and Lung Carcinogenesis. Carcinogenesis, 32, 1299-1304. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
De Herreros, A.G., Peiró, S., Nassour, M., et al. (2010) Snail Family Regulation and Epithelial Mesenchymal Transitions in Breast Cancer Progression. Journal of Mammary Gland Biology and Neoplasia, 15, 135-147. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Ugolkov, A.V., Matsangou, M., Taxter, T.J., et al. (2018) Aber-rant Expression of Glycogen Synthase Kinase-3β in Human Breast and Head and Neck Cancer. Oncology Letters, 16, 6437-6444. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Bachelder, R.E., Yoon, S.O., Franci, C., et al. (2005) Gly-cogen Synthase Kinase-3 Is an Endogenous Inhibitor of Snail Transcription: Implications for the Epithelial-Mesenchymal Transition. Journal of Cell Biology, 168, 29-33. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Huber, M.A., Azoitei, N., Baumann, B., et al. (2004) NF-kappaB Is Essential for Epithelial-Mesenchymal Transition and Metastasis in a Model of Breast Cancer Progression. Journal of Clinical Investigation, 114, 569-581. [Google Scholar] [CrossRef]
|
|
[31]
|
Davis, N.M., Sokolosky, M., Stadelman, K., et al. (2014) Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 Pathway in Breast Cancer: Possibilities for Therapeutic Intervention. Oncotar-get, 5, 4603-4650. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Guo, C., Li, S., Liang, A., et al. (2021) PPA1 Promotes Breast Can-cer Proliferation and Metastasis through PI3K/AKT/GSK3β Signaling Pathway. Frontiers in Cell and Developmental Bi-ology, 9, Article ID: 730558. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Kim, Y.C. and Guan, K.L. (2015) mTOR: A Pharmacologic Target for Autophagy Regulation. Journal of Clinical Investigation, 125, 25-32. [Google Scholar] [CrossRef]
|
|
[34]
|
Wullschleger, S., Loewith, R. and Hall, M.N. (2006) TOR Signaling in Growth and Metabolism. Cell, 124, 471-484. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Proud, C.G. (2011) mTOR Signalling in Health and Disease. Bio-chemical Society Transactions, 39, 431-436. [Google Scholar] [CrossRef]
|
|
[36]
|
Wander, S.A., Hennessy, B.T. and Slingerland, J.M. (2011) Next-Generation mTOR Inhibitors in Clinical Oncology: How Pathway Complexity Informs Therapeutic Strategy. Jour-nal of Clinical Investigation, 121, 1231-1241. [Google Scholar] [CrossRef]
|
|
[37]
|
Ougolkov, A.V., Fernandez-Zapico, M.E., Bilim, V.N., et al. (2006) Aber-rant Nuclear Accumulation of Glycogen Synthase Kinase-3beta in Human Pancreatic Cancer: Association with Kinase Activity and Tumor Dedifferentiation. Clinical Cancer Research, 12, 5074-5081. [Google Scholar] [CrossRef]
|
|
[38]
|
Ougolkov, A.V., Bone, N.D., Fernandez-Zapico, M.E., et al. (2007) Inhibition of Glycogen Synthase Kinase-3 Activity Leads to Epigenetic Silencing of Nuclear Factor kappaB Target Genes and Induction of Apoptosis in Chronic Lymphocytic Leukemia B Cells. Blood, 110, 735-742. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Ren, Y., Bao, G., Yang, H., et al. (2022) Ethiadin Induces Apoptosis and Suppresses Growth of MCF-7 Breast Cancer Cells by Regulating the Phosphorylation of Glycogen Syn-thase Kinase 3 Beta (GSK3beta). Discovery Medicine, 33, 55-67.
|
|
[40]
|
Chandra, P., Sachan, N. and Pal, D. (2021) Gly-cogen Synthase Kinase-3 (GSK-3) Inhibitors as a New Lead for Treating Breast and Ovarian Cancer. Current Drug Targets, 22, 1548-1554. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Ugolkov, A., Gaisina, I., Zhang, J.S., et al. (2016) GSK-3 Inhibition Overcomes Chemoresistance in Human Breast cancer. Cancer Letters, 380, 384-392. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Azoulay-Alfaguter, I., Elya, R., Avrahami, L., et al. (2015) Com-bined Regulation of mTORC1 and Lysosomal Acidification by GSK-3 Suppresses Autophagy and Contributes to Cancer Cell Growth. Oncogene, 34, 4613-4623. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Inoki, K., Ouyang, H., Zhu, T., et al. (2006) TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth. Cell, 126, 955-968. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Sengupta, S., Peterson, T.R. and Sabatini, D.M. (2010) Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress. Molecular Cell, 40, 310-322. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Suzuki, T., Bridges, D., Nakada, D., et al. (2013) Inhibition of AMPK Catabolic Action by GSK3. Molecular Cell, 50, 407-419. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Guo, L., Chen, D., Yin, X., et al. (2019) GSK-3β Promotes Cell Migration and Inhibits Autophagy by Mediating the AMPK Pathway in Breast Cancer. Oncology Research, 27, 487-494. [Google Scholar] [CrossRef]
|
|
[47]
|
Rim, E.Y., Clevers, H. and Nusse, R. (2022) The Wnt Pathway: From Signaling Mechanisms to Synthetic Modulators. Annual Review of Biochemistry, 91, 571-598. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Li, V.S., Ng, S.S., Boersema, P.J., et al. (2012) Wnt Signaling through Inhibition of β-Catenin Degradation in an Intact Axin1 Complex. Cell, 149, 1245-1256. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Martens, J.W., Nimmrich, I., Koenig, T., et al. (2005) Association of DNA Methylation of Phosphoserine Aminotransferase with Response to Endocrine Therapy in Patients with Recur-rent Breast Cancer. Cancer Research, 65, 4101-4117. [Google Scholar] [CrossRef]
|
|
[50]
|
Gao, S., Ge, A., Xu, S., et al. (2017) PSAT1 Is Regulated by ATF4 and Enhances Cell Proliferation via the GSK3β/β-Catenin/Cyclin D1 Signaling Pathway in ER-Negative Breast Cancer. Journal of Experimental & Clinical Cancer Research, 36, Article No. 179. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Jamieson, C., Sharma, M. and Henderson, B.R. (2012) Wnt Sig-naling from Membrane to Nucleus: β-Catenin Caught in a Loop. The International Journal of Biochemistry & Cell Biol-ogy, 44, 847-850. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Quintayo, M.A., Munro, A.F., Thomas, J., et al. (2012) GSK3β and Cyclin D1 Expression Predicts Outcome in Early Breast Cancer Patients. Breast Cancer Research and Treatment, 136, 161-168. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Qie, S. and Diehl, J.A. (2016) Cyclin D1, Cancer Progression, and Opportunities in Cancer Treatment. Journal of Molecular Medicine (Berl), 94, 1313-1326. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Stoll, B.A. (2002) Upper Abdominal Obesity, Insulin Resistance and Breast Cancer Risk. International Journal of Obesity, 26, 747-753. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Mantzoros, C., Petridou, E., Dessypris, N., et al. (2004) Adiponectin and Breast Cancer Risk. The Journal of Clinical Endocrinology & Metabolism, 89, 1102-1107. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Wang, Y., Lam, J.B., Lam, K.S., et al. (2006) Adiponectin Modulates the Glycogen Synthase Kinase-3beta/Beta-Catenin Signaling Pathway and Attenuates Mammary Tumorigenesis of MDA-MB-231 Cells in Nude Mice. Cancer Research, 66, 11462-11470. [Google Scholar] [CrossRef]
|